Black tea consumption dose-dependently improves flow-mediated dilation in healthy males.

Department of Internal Medicine and Public Health, University of L'Aquila, L'Aquila, Italy.
Journal of Hypertension (Impact Factor: 4.22). 04/2009; 27(4):774-81. DOI: 10.1097/HJH.0b013e328326066c
Source: PubMed

ABSTRACT Flavonoids may protect against cardiovascular disease. Tea is a major source of dietary flavonoids. Studies indicate black tea improves endothelial function but data on arterial haemodynamics, blood pressure (BP) and insulin resistance are equivocal. Inconsistency may be due to flaws in study design or flavonoid doses tested. Further, no study has evaluated the dose-response curve. Our study aimed to test the effects of various doses of black tea on vascular function, BP and insulin resistance.
According to a randomized, double-blind, controlled, cross-over design, 19 healthy men were assigned to receive either five treatments with a twice daily intake of black tea (0, 100, 200, 400 and 800 mg tea flavonoids/day) in five periods lasting 1 week each.
Black tea dose dependently increased flow-mediated dilation (FMD) from 7.8% (control) to 9.0, 9.1, 9.6 and 10.3% after the different flavonoid doses, respectively (P = 0.0001). Already 100 mg/day (less than 1 cup of tea) increased FMD compared with control (P = 0.0113). FMD improvement after 800 mg/day was significant compared with control (P < 0.0001) but also to 100 mg/day (P = 0.0121) and 200 mg/day (P = 0.0275). Black tea intake decreased office systolic (-2.6 mmHg, P = 0.0007) and diastolic (-2.2 mmHg, P = 0.006) BP as well as stiffness index (P = 0.0159) without changes in other parameters studied.
Our study is the first showing black tea ingestion dose dependently improved FMD and decreased peripheral arterial stiffness in healthy volunteers. Our data suggest that worldwide all tea drinkers could benefit from protective cardiovascular effects exerted by tea.

Download full-text


Available from: Claudio Ferri, Jul 02, 2015
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Epidemiological evidence has linked consumption of black tea, produced from Camellia sinensis, with a reduced risk of cardiovascular diseases. However, intervention studies on the effects of tea consumption on blood pressure (BP) have reported inconsistent results. Our objective was to conduct a systematic literature review with meta-analysis of controlled human intervention studies examining the effect of tea consumption on BP.
    PLoS ONE 07/2014; 9(7):e103247. DOI:10.1371/journal.pone.0103247 · 3.53 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Background & Aims The results of randomized controlled trials in relation to the effect of regular black tea consumption on serum cholesterol concentration were inconsistent. We aimed to investigate and quantify the effect of black tea consumption on serum concentrations of total, LDL and HDL cholesterol. Methods We systematically searched and identified relevant literatures in PubMed, Scopus and the Cochrane Library. Inclusion and exclusion of studies, data extraction, quality assessment and meta-analysis were conducted according to the PRISMA statement. Results Ten eligible studies with 411 participants were identified in the present meta-analysis. No significant heterogeneity was found between studies. Consumption of black tea significantly reduced LDL cholesterol concentration (-4.64 mg/dL; 95% CI: -8.99, -0.30 mg/dL; P = 0.036). No remarkable change was detected in total cholesterol (-2.04 mg/dL; 95% CI: -6.43, 2.35 mg/dL; P = 0.363) or HDL cholesterol (-1.15 mg/dL; 95% CI: -3.04, 0.75 mg/dL; P = 0.236). Subgroup analysis showed that the lowering effect on LDL cholesterol was more effective in subjects with higher cardiovascular risk. Conclusions Black tea consumption significantly lowered serum concentration of LDL cholesterol, especially in subjects with higher cardiovascular risk. Black tea intake did not impose obvious effect on serum concentrations of total and HDL cholesterol.
    Clinical Nutrition 06/2014; 34(4). DOI:10.1016/j.clnu.2014.06.003 · 3.94 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Endothelium-bound extracellular superoxide dismutase (eEC-SOD), a major antioxidative enzyme in the vasculature, is involved in anti-atherogenesis by inhibiting low-density lipoprotein (LDL) oxidation. The objective was to investigate whether the polyphenol-rich juar tea had beneficial effects on LDL oxidation and eEC-SOD levels in patients with metabolic syndrome (MetS). A total of 20 men with MetS participated in a randomized cross-over trial, comparing consumption of five cups/day of juar tea with that of a polyphenol-poor tea, barley tea, for 4 weeks. Although there was no change in LDL oxidizability after consumption of either tea, juar tea significantly increased eEC-SOD levels by 16% (p < 0.05), whereas barley tea significantly decreased levels by 15% (p < 0.05). It is noteworthy that the changes in eEC-SOD were positively associated with those in LDL oxidizability after tea consumption (r (2) = 0.11, p < 0.05). Tea polyphenols may provide anti-atherosclerotic effects by inhibiting LDL oxidation through EC-SOD bound to the endothelium.
    International Journal of Food Sciences and Nutrition 01/2013; DOI:10.3109/09637486.2012.759185 · 1.20 Impact Factor